Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Lyrica

PRIVATE STATUS
Description

Provider of oral drugs. The company provides oral medicines developed for the treatment of neuropathic pain and treats two of the most common forms of nerve pain, namely diabetic peripheral neuropathy ("DPN") and post-herpetic neuralgia ("PHN") and is applicable to a broad range of other disorders.

Website
Ownership Status
Privately Held (no backing)
Financing Status
Corporation
Primary Industry
Drug Delivery
Primary Office
  • 235 East 42nd Street
  • New York, NY 10017
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Lyrica’s full profile, request a free trial.